American manufacturer K Pharmaceuticals has launched Aquoral, an oral spray for dry mouth. With two quick sprays, the new product is said to lubricate and provide a protective shield that helps the oral mucosa retain moisture to provide quick relief that lasts for four to six hours, which reduces the need for frequent dosing.
According to the company, Aquoral differs from aqueous-based treatments that requires patients to rinse-and-repeat up to 10 times a day or to be mixed with water. It utilises Oxidised Glycerol Triesters (OGT), a plant-derived, lipid-based technology.
Also known as xerostomia, dry mouth is a common condition caused by disease, medication side effects, or other factors that result in discomfort or pain and may affect the ability to chew, taste, swallow, and speak. Common causes of the condition include cancer treatment, sleep apena, diabetes and Sjögren’s Disease, according to the manufacturer.
“Dry mouth is an under-reported and important condition that can lead to serious complications, especially in cancer patients,” said Sheryl Riley RN, OCN, CMCN, founding partner of Clarion, a firm specialising in oncology care management. “Over-the-counter remedies provide temporary relief but do not protect the oral cavity. Aquoral forms a long-lasting protective barrier over the entire mouth, reducing moisture loss and maintaining the patient’s comfort and quality of life.”
Previously marketed as Xerostomia Relief Spray and available only to dentists, Aquoral can now prescribed by all licensed healthcare professionals.
“As a pharmacist who specialises in oral medicine, I know that many prescriptions and over-the-counter medications can cause xerostomia, which may negatively affect daily living activities and also result in oral health issues, such as gingivitis, periodontal disease, or mucositis,” said Thomas Viola, RPh, CCP. “It has been my experience that lipid-based therapies, such as Aquoral, are superior to water-based formulas in helping to prevent oral disease and provide long-lasting relief.”